CI
DXCM icon

Clal Insurance’s DexCom DXCM Stock Holding History

Clal Insurance’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5K Sell
72
-40
-36% -$2.67K ﹤0.01% 209
2026
Q1 		$7K Sell
112
-19,939
-99% -$1.39M ﹤0.01% 195
2025
Q4 		$1.33M Buy
20,051
+14,051
+234% +$908K 0.01% 105
2025
Q3 		$404K Buy
+6,000
New +$475K ﹤0.01% 115
2024
Q4 		– Sell
-13,500
Closed -$905K – 193
2024
Q3 		$905K Buy
+13,500
New +$1.11M 0.01% 96
2021
Q3 		– Sell
-6,000
Closed -$641K – 225
2021
Q2 		$641K Buy
+6,000
New +$576K 0.01% 164

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance's DXCM Position: Q2 2026 in Review

Clal Insurance reduced its DexCom (DXCM) stake by 36% in Q2 2026, selling an estimated $2.67K and leaving 72 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #209.

Clal Insurance first reported a position in DXCM in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.33M in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Clal Insurance held 72 shares of DexCom worth $5K as of Q2 2026.
  • Clal Insurance sold 40 DexCom shares in Q2 2026, an estimated $2.67K.
  • DexCom made up ﹤0.01% of Clal Insurance's portfolio in Q2 2026, its #209 holding.
  • Clal Insurance first reported a position in DexCom in Q2 2021 and has held it in 6 quarters since.
  • Clal Insurance's DexCom position peaked at $1.33M in Q4 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.